FBXW7 and hepatocellular carcinoma: Loss of FBXW7 expression has been observed in several human cancers, such as hepatocellular carcinoma [13], gastric cancer [14], breast cancer [15], blood cancer [16], colorectal cancer [17] and pancreatic cancer [18].